Simultaneous kinetics of oral vorinostat in plasma and cerebrospinal fluid in a patient with cutaneous T-cell lymphoma with CNS involvement

Int J Clin Pharmacol Ther. 2023 Jun;61(6):270-272. doi: 10.5414/CP204364.
No abstract available

MeSH terms

  • Antineoplastic Agents* / therapeutic use
  • Humans
  • Kinetics
  • Lymphoma, T-Cell, Cutaneous* / drug therapy
  • Lymphoma, T-Cell, Cutaneous* / pathology
  • Skin Neoplasms* / drug therapy
  • Vorinostat / therapeutic use

Substances

  • Vorinostat
  • Antineoplastic Agents